Pharmacokinetics and organ distribution of intravenous and oral methylene blue

[1]  D. Schrijvers,et al.  ©2000 Cancer Research Campaign Article no. bjoc.1999.0917 , 2022 .

[2]  J. Merrer,et al.  Encéphalopathie à l'ifosfamide. À propos de deux cas , 1999 .

[3]  J. Merrer,et al.  [Ifosfamide-related encephalopathy. Report of two cases]. , 1999, La Revue de medecine interne.

[4]  T. Buclin,et al.  Spectrophotometric determination of methylene blue in biological fluids after ion-pair extraction and evidence of its adsorption on plastic polymers , 1997 .

[5]  Y. Nieto,et al.  Ifosfamide encephalopathy and methylene-blue: a case report. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  P. Ell,et al.  Targeting disseminated melanoma with radiolabelled methylene blue: Comparative bio-distribution studies in man and animals. , 1996, Acta oncologica.

[7]  T. Cerny,et al.  Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy , 1996, European Journal of Clinical Pharmacology.

[8]  Kristina J. Liu,et al.  Report of two cases , 1995 .

[9]  B. Maton,et al.  Methylene blue for ifosfamide-associated encephalopathy. , 1995, The New England journal of medicine.

[10]  B. Wermuth,et al.  Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue , 1994, The Lancet.

[11]  T. Cerny,et al.  The enigma of ifosfamide encephalopathy. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  M. Inbar,et al.  Ifosfamide-related acute encephalopathy: clinical and radiological aspects. , 1991, European journal of cancer.

[13]  J. Wagner,et al.  Pharmacokinetics of highly ionized drugs. 3. Methylene blue--blood levels in the dog and tissue levels in the rat following intravenous administration. , 1972, Journal of pharmaceutical sciences.

[14]  J. Wagner,et al.  Pharmacokinetics of highly ionized drugs. I. Methylene blue--whole blood, urine, and tissue assays. , 1972, Journal of pharmaceutical sciences.